Up to present, Xingmei Biotech Co., Ltd., Xingsiyi Biotech Co., Ltd. and Tianjin Xinglian Peptide Biotech Co., Ltd. invested by Fosun Haihe Medical Health Industry Fund have settled in the Airport Economic Area. In the future, Zhongke Fosun Tianjin Bio-industry Base will also cooperate with Tianjin Institute of Industrial Biotechnology of Chinese Academy of Sciences to provide platforms and industrial services for investment and incubation projects, and create a comprehensive chain of bio-industry results transformation platform. The Bio-manufacturing Valley has initially taken the shape of the integrated development pattern of "technological innovation - transformation of achievements - industrial application - feeding innovation".
　　In 2022, Tianjin Port Free Trade Zone will promote the construction of Bio-Manufacturing Valley, and continue to amplify the attraction effect of "Bio-Manufacturing Valley" based on the construction of Haihe Laboratory, attract a number of high-quality projects to establish businesses, strengthen the innovation chain of bio-manufacturing industry chain, and achieve cluster-based development. Meanwhile, the two major focuses of investment promotion and project construction will be pursued, so as to form a strong atmosphere of "highlighting projects, developing enterprises, strengthening entities and promoting development", and strive to create the optimal business environment and provide "overall life cycle" services to ensure the early commencement and completion of projects and contribute to the construction of Tianjin as a national hub for biomanufacturing industries.